Maastricht University Medical Center+

Maastricht, Limburg 6229 HX

3 studies enrolling now · 12 studies all time

What they study most

BRAF or NRAS Mutant Metastatic Melanoma, BRCA1 Gene Mutation, BRCA2 Gene Mutation, BRIP1 Gene Mutation, Basal Cell Carcinoma, Bone Marrow Disease, Bronchopulmonary Dysplasia, Cardiac Diseases, Cervical Cancer, Chronic Lung Disease of Prematurity, Colorectal Cancer Liver Metastases, Colorectal Cancer Liver Metastases (CRLM)

Studies at this site

• TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention — Recruiting now
• The DRAGON 2 Trial — Recruiting now
• Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome — Running, not enrolling
• A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants — Running, not enrolling
• A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies — Completed
• An International Multicenter, Multivendor Evaluation of the Free-Running Framework for Cardiac Function — Starting soon
• Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma — Completed
• Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy — Completed
• A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma — Completed
• DRAGON 1- Training, Accreditation, Implementation and Safety Evaluation of Combined PVE/HVE — Status unconfirmed
• Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy — Completed
• Predicting Reduction of Hypertension After Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis — Completed